-transparent.png){kind=logo}
During the course of a study of the hypoglycemic effects of nicotinic acid and chromium on humans, two hypercholesterolemic subjects were found to experience clinically significant decreases in serum cholesterol levels. These subjects have now been followed for one year. The first subject had a cholesterol level of 10.33 mmol/L (399 mg/dL). Daily supplementation for four weeks with 100 mg of nicotinic acid (niacin) and 200 micrograms of chromium chloride led to a decrease in serum cholesterol to 8.86 mmol/L (342 mg/dL). Further supplementation for four months led to a further decrease in serum cholesterol to 7.25 mmol/L (280 mg/dL). The second subject had a cholesterol level of 8.73 mmol/L (337 mg/dL). Four weeks of supplementation lowered the level to 6.73 mmol/L (260 mg/dL). When supplementation was discontinued, the cholesterol level rose slightly. When supplementation was reinstituted, the cholesterol level decreased to 6.68 mmol/L (258 mg/dL).
M Urberg, and
J Benyi, and
R John
May 1961,
New York state journal of medicine,
M Urberg, and
J Benyi, and
R John
February 1962,
La Prensa medica mexicana,
M Urberg, and
J Benyi, and
R John
December 1996,
Biological trace element research,
M Urberg, and
J Benyi, and
R John
July 1959,
Diseases of the nervous system,
M Urberg, and
J Benyi, and
R John
July 1963,
Minerva medica,
M Urberg, and
J Benyi, and
R John
April 1962,
Boletin del Instituto de Estudios Medicos y Biologicos, Universidad Nacional Autonoma de Mexico,
M Urberg, and
J Benyi, and
R John
January 1983,
Artery,
M Urberg, and
J Benyi, and
R John
June 2010,
British poultry science,
M Urberg, and
J Benyi, and
R John
September 1961,
La Clinica terapeutica,
M Urberg, and
J Benyi, and
R John
March 1985,
The American journal of clinical nutrition,
